Eva M. Carrasco
San Sebastian De Los Reyes, MD 28703, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Clinical and pathologic insights into early and late breast cancer relapses: a real-world analysis from the El Álamo IV registry.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 05, 2026
Author Correction: Advancing equitable access to innovation in breast cancer.
Journal: NPJ breast cancer
Published: December 16, 2025
Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies.
Journal: Breast cancer research : BCR
Published: September 10, 2025
Advancing equitable access to innovation in breast cancer.
Journal: NPJ breast cancer
Published: April 03, 2025
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 08, 2024
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Journal: Breast cancer research and treatment
Published: March 27, 2023
A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer.
Journal: Future oncology (London, England)
Published: April 25, 2022
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 20, 2021
Last Updated: 09/26/2026